Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau.

Image processing with ImageJ

Abràmoff, M. D., Magalhães, P. J., & Ram, S. J. (2004) · Utrecht University Repository (Utrecht University) · Cited by 11,816

Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient

Stejskal, E. O., & Tanner, J. E. (1965) · The Journal of Chemical Physics · doi:10.1063/1.1695690 · Cited by 8,239

Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

Fisher, R. S., Boas, W. V. E., Blume, W. T., Elger, C. E., Genton, P., Lee, P., & Engel, J. (2005) · Epilepsia · doi:10.1111/j.0013-9580.2005.66104.x · Cited by 3,678

Comment on Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE)

Beghi, E., Berg, A. T., Carpio, A., Forsgren, L., Hesdorffer, D. C., Hauser, W. A., Malmgren, K., Shinnar, S., Temkin, N. R., Thurman, D. J., et al. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00273_1.x · Cited by 2,301

Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling

Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,927

Automatic quantitation of localized in vivo1H spectra with LCModel

Provencher, S. W. (2001) · NMR in Biomedicine · doi:10.1002/nbm.698 · Cited by 1,640

Serine/threonine phosphatases: mechanism through structure

Shi, Y. (2009) · Cell · doi:10.1016/j.cell.2009.10.006 · Cited by 1,488

Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease

Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269

Multinuclear NMR Studies on the Energy Metabolism of Glial and Neuronal Cells

Brand, A., Richter‐Landsberg, C., & Leibfritz, D. (1994) · Developmental Neuroscience · doi:10.1159/000111347 · Cited by 889

Kindling and status epilepticus models of epilepsy: rewiring the brain

Morimoto, K., Fahnestock, M. L., & Racine, R. J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.009 · Cited by 854

Tau-targeting therapies for Alzheimer disease

Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113

Tau-based therapies in neurodegeneration: opportunities and challenges

Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272

Seizures and Epilepsy After Stroke: Epidemiology, Biomarkers and Management

Galovic, M., Ferreira‐Atuesta, C., Abraira, L., Döhler, N., Sinka, L., Brigo, F., Bentes, C. C., Zelano, J., & Koepp, M. J. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00837-7 · Cited by 202

Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy.

Gourmaud, S., Shou, H., Irwin, D. J., Sansalone, K., Jacobs, L. M., Lucas, T. H., Marsh, E. D., Davis, K. A., Jensen, F. E., & Talos, D. M. (2020) · Brain · doi:10.1093/brain/awz381 · Cited by 155

KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy

Shekh‐Ahmad, T., Eckel, R., Naidu, S. D., Higgins, M., Yamamoto, M. P., Dinkova‐Kostova, A. T., Kovac, S., Abramov, A. Y., & Walker, M. C. (2018) · Brain · doi:10.1093/brain/awy071 · Cited by 150

Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain

Semple, B. D., O'Brien, T. J., Gimlin, K., Wright, D. K., Kim, S. E., Casillas-Espinosa, P. M., Webster, K. M., Petrou, S., & Noble‐Haeusslein, L. J. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0982-17.2017 · Cited by 136

Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions

Golub, V. M., & Reddy, D. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000375 · Cited by 116

New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives

Mühlebner, A., Bongaarts, A., Sarnat, H. B., Scholl, T. O., & Aronica, E. (2019) · Journal of Anatomy · doi:10.1111/joa.12956 · Cited by 98

The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy

Wilcox, K. S., West, P. J., & Metcalf, C. S. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107811 · Cited by 86

Sodium selenate activated Wnt/β-catenin signaling and repressed amyloid-β formation in a triple transgenic mouse model of Alzheimer's disease

Jin, N., Zhu, H., Liang, X., Huang, W., Xie, Q., Xiao, P., Ni, J., & Liu, Q. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.006 · Cited by 85

Pre-Clinical Testing of Therapies for Traumatic Brain Injury

DeWitt, D. S., Hawkins, B. E., Dixon, C. E., Kochanek, P. M., Armstead, W. M., Bass, C. R., Bramlett, H. M., Büki, A., Dietrich, W. D., Ferguson, A. R., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5778 · Cited by 87

Epilepsy in Neurodegenerative Diseases: Related Drugs and Molecular Pathways

Cano, A. C., Fonseca, E., Ettcheto, M., Sánchez‐López, E., de Rojas, I., Alonso-Lana, S., Morató, X., Souto, E. B., Toledo, M., Boada, M., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14101057 · Cited by 90

Tau hyperphosphorylation and P-CREB reduction are involved in acrylamide-induced spatial memory impairment: Suppression by curcumin

Yan, D., Yao, J., Liu, Y., Zhang, X., Wang, Y., Chen, X., Liu, L., Shi, N., & Yan, H. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.04.014 · Cited by 82

Treatment with an interleukin-1 receptor antagonist mitigates neuroinflammation and brain damage after polytrauma

Sun, M., Brady, R. D., Wright, D. K., Kim, H. A., Zhang, S. R., Sobey, C. G., Johnstone, M. R., O'Brien, T. J., Semple, B. D., McDonald, S. J., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.005 · Cited by 80

In search of antiepileptogenic treatments for post-traumatic epilepsy

Saletti, P. G., Ali, I. Y., Casillas-Espinosa, P. M., Semple, B. D., Lisgaras, C. P., Moshé, S. L., & Galanopoulou, A. S. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.017 · Cited by 75

Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human injured brain

Zheng, P., Zhang, N., Ren, D., Yu, C., Zhao, B., & Zhang, Y. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101057 · Cited by 71

Insights into epileptogenesis from post-traumatic epilepsy

Pease, M. W., Gupta, K., Moshé, S. L., Correa, D. J., Galanopoulou, A. S., Okonkwo, D. O., Gonzalez-Martinez, J. A., Shutter, L., Diaz-Arrastia, R. R., & Castellano, J. F. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00954-y · Cited by 72

Sodium selenate, a protein phosphatase 2A activator, mitigates hyperphosphorylated tau and improves repeated mild traumatic brain injury outcomes

Tan, X. L., Wright, D. K., Liu, S., Hovens, C. M., O'Brien, T. J., & Shultz, S. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.05.001 · Cited by 68

Modelling traumatic brain injury and posttraumatic epilepsy in rodents

Brady, R. D., Casillas-Espinosa, P. M., Agoston, D. V., Bertram, E. H., Kamnaksh, A., Semple, B. D., & Shultz, S. R. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.007 · Cited by 70

Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways

Canet, G., Zub, E., Zussy, C., Hernandez, C., Blaquière, M., Garcia, V., Vitalis, M., de Bock, F., Moreno, M. P., Audinat, É., et al. (2022) · Epilepsia · doi:10.1111/epi.17186 · Cited by 65

Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy

Reddy, S. D., Younus, I., Sridhar, V., & Reddy, D. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010220 · Cited by 64

Changes in Apparent Fiber Density and Track-Weighted Imaging Metrics in White Matter following Experimental Traumatic Brain Injury

Wright, D. K., Johnston, L. A., Kershaw, J., Ordidge, R. J., O'Brien, T. J., & Shultz, S. R. (2017) · Journal of Neurotrauma · doi:10.1089/neu.2016.4730 · Cited by 60

Neurodegenerative pathways as targets for acquired epilepsy therapy development

Casillas-Espinosa, P. M., Ali, I. Y., & O'Brien, T. J. (2020) · Epilepsia Open · doi:10.1002/epi4.12386 · Cited by 59

Neuropathophysiological Mechanisms and Treatment Strategies for Post-traumatic Epilepsy

Sharma, S., Tiarks, G., Haight, J. A., & Bassuk, A. G. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.612073 · Cited by 58

Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences

Webster, K. M., Shultz, S. R., Öztürk, E., Dill, L. K., Sun, M., Casillas-Espinosa, P. M., Jones, N. C., Crack, P. J., O'Brien, T. J., & Semple, B. D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.112979 · Cited by 55

Interweaving epilepsy and neurodegeneration: Vitamin E as a treatment approach

Upaganlawar, A. B., Wankhede, N. L., Kale, M. B., Umare, M. D., Sehgal, A., Singh, S., Bhatia, S., Al-Harrasi, A., Najda, A., Nurzyńska-Wierdak, R., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112146 · Cited by 53

Selenium supplementation enhanced the expression of selenoproteins in hippocampus and played a neuroprotective role in LPS-induced neuroinflammation

Liang, X., Xue, Z., Zheng, Y., Li, S., Zhou, L., Cao, L., & Zou, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123740 · Cited by 50

Novel Approaches to Prevent Epileptogenesis After Traumatic Brain Injury

Dulla, C. G., & Pitkänen, A. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01119-1 · Cited by 46

Antiepileptogenesis and disease modification: Progress, challenges, and the path forward—Report of the Preclinical Working Group of the 2018 NINDS‐sponsored antiepileptogenesis and disease modification workshop

Galanopoulou, A. S., Löscher, W., Lubbers, L. S., O'Brien, T. J., Staley, K. J., Vezzani, A., D’Ambrosio, R., White, H. S., Sontheimer, H. W., Wolf, J. A., et al. (2021) · Epilepsia Open · doi:10.1002/epi4.12490 · Cited by 46

Harmonization of lateral fluid-percussion injury model production and post-injury monitoring in a preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis

Ndode‐Ekane, X. E., Santana‐Gomez, C., Casillas-Espinosa, P. M., Ali, I. Y., Brady, R. D., Smith, G. S., Andrade, P., Immonen, R. J., Puhakka, N., Hudson, M. R., et al. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.01.006 · Cited by 41

A universal automated tool for reliable detection of seizures in rodent models of acquired and genetic epilepsy

Casillas-Espinosa, P. M., Sargsyan, A. R., Melkonian, D., & O'Brien, T. J. (2019) · Epilepsia · doi:10.1111/epi.14691 · Cited by 43

The need to incorporate aged animals into the preclinical modeling of neurological conditions

Sun, M., McDonald, S. J., Brady, R. D., Collins‐Praino, L. E., Yamakawa, G. R., Monif, M., O'Brien, T. J., CLOUD, G. C., Sobey, C. G., Mychasiuk, R., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.027 · Cited by 44

Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease

Paudel, Y. N., Angelopoulou, E., Jones, N. C., O'Brien, T. J., Kwan, P., Piperi, C., Othman, I., & Shaikh, M. F. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00460 · Cited by 42

An update on the association between traumatic brain injury and Alzheimer’s disease: Focus on Tau pathology and synaptic dysfunction

Li, L., Liang, J., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.020 · Cited by 42

Epilepsy After Traumatic Brain Injury

Pitkänen, A., Kyyriäinen, J., Andrade, P., Pasanen, L., & Ndode‐Ekane, X. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00046-8 · Cited by 42

Disease-modifying effects of a novel T-type calcium channel antagonist, Z944, in a model of temporal lobe epilepsy

Casillas-Espinosa, P. M., Shultz, S. R., Braine, E. L., Jones, N. C., Snutch, T. P., Powell, K. L., & O'Brien, T. J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101677 · Cited by 41

Recent Developments in Diagnosis of Epilepsy: Scope of MicroRNA and Technological Advancements

Bandopadhyay, R., Singh, T., Ghoneim, M. M., Alshehri, S., Angelopoulou, E., Paudel, Y. N., Piperi, C., Ahmad, J., Alhakamy, N. A., Alfaleh, M. A., et al. (2021) · Biology · doi:10.3390/biology10111097 · Cited by 44

Accelerated kindling epileptogenesis in Tg4510 tau transgenic mice, but not in tau knockout mice

Liu, S., Shen, Y., Shultz, S. R., Nguyen, A., Hovens, C. M., Adlard, P. A., Bush, A. I., Chan, J., Kwan, P., O'Brien, T. J., et al. (2017) · Epilepsia · doi:10.1111/epi.13847 · Cited by 39

Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau

Paudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., & Shaikh, M. F. (2020) · Biology · doi:10.3390/biology9060122 · Cited by 44

Targeting neurodegeneration to prevent post-traumatic epilepsy.

Ali, I., Silva, J. C., Liu, S., Shultz, S. R., Kwan, P., Jones, N. C., & O'Brien, T. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.08.006 · Cited by 38

Astrocytic Insulin-Like Growth Factor-1 Protects Neurons Against Excitotoxicity

Chen, W., He, B., Tong, W., Zeng, J., & Zheng, P. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00298 · Cited by 37

Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy

Casillas-Espinosa, P. M., Anderson, A., Harutyunyan, A., Li, C. N., Lee, J.-Y., Braine, E. L., Brady, R. D., Sun, M., Huang, C., Barlow, C. K., et al. (2023) · eLife · doi:10.7554/elife.78877 · Cited by 37

Voyage of selenium from environment to life: Beneficial or toxic?

Banerjee, M., Chakravarty, D., Kalwani, P., & Ballal, A. D. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23195 · Cited by 39

Tauopathy and Epilepsy Comorbidities and Underlying Mechanisms

Hwang, K., Vaknalli, R. N., Addo-Osafo, K., Vicente, M., & Vossel, K. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903973 · Cited by 35

Transactive Response DNA-Binding Protein 43 Abnormalities after Traumatic Brain Injury

Tan, X. L., Sun, M., Brady, R. D., Liu, S., Llanos, R. M., Cheung, S., Wright, D. K., Casillas-Espinosa, P. M., Sashindranath, M., O'Brien, T. J., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5491 · Cited by 36

Sodium selenate treatment improves symptoms and seizure susceptibility in a malin‐deficient mouse model of Lafora disease

Sánchez‐Elexpuru, G., Serratosa, J. M., & Sánchez, M. P. (2017) · Epilepsia · doi:10.1111/epi.13656 · Cited by 34

Central nervous system lymphatic unit, immunity, and epilepsy: Is there a link?

Noè, F. M., & Marchi, N. (2019) · Epilepsia Open · doi:10.1002/epi4.12302 · Cited by 33

Harmonization of the pipeline for seizure detection to phenotype post-traumatic epilepsy in a preclinical multicenter study on post-traumatic epileptogenesis

Casillas-Espinosa, P. M., Andrade, P., Santana‐Gomez, C., Paananen, T., Smith, G. S., Ali, I. Y., Ciszek, R., Ndode‐Ekane, X. E., Brady, R. D., Tohka, J., et al. (2019) · Epilepsy Research · doi:10.1016/j.eplepsyres.2019.04.011 · Cited by 33

Hyperphosphorylated Tau in Mesial Temporal Lobe Epilepsy: a Neuropathological and Cognitive Study

Toscano, E. C. D. B., Vieira, É. L. M., Grinberg, L. T., Rocha, N. P., Brant, J. A. S., Paradela, R. S., Giannetti, A. V., Suemoto, C. K., Leite, R. E. P., Nitríni, R., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-022-03190-x · Cited by 33

Zebrafish model of posttraumatic epilepsy.

Cho, S., Park, E., Telliyan, T., Baker, A., & Reid, A. Y. (2020) · Epilepsia · doi:10.1111/epi.16589 · Cited by 29

Cognitive deficits in a rat model of temporal lobe epilepsy using touchscreen‐based translational tools

Carron, S. F., Dezsi, G., Öztürk, E., Nithianantharajah, J., & Jones, N. C. (2019) · Epilepsia · doi:10.1111/epi.16291 · Cited by 28

Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy

Aroor, A., Nguyen, P., Li, Y., Das, R. R., Lugo, J. N., & Brewster, A. L. (2023) · Epilepsia Open · doi:10.1002/epi4.12744 · Cited by 26

Microtubule Dynamics and Neuronal Excitability: Advances on Cytoskeletal Components Implicated in Epileptic Phenomena

Gambino, G., Rizzo, V., Giglia, G., Ferraro, G., & Sardo, P. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00963-7 · Cited by 26

Mechanistic and therapeutic relationships of traumatic brain injury and γ-amino-butyric acid (GABA)

Witkin, J. M., Shafique, H. S., Cerne, R., Smith, J. L., Marini, A. M., Lipsky, R. H., & Delery, E. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108609 · Cited by 26

Evolving targets for anti-epileptic drug discovery

Raut, D., & Bhatt, L. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173582 · Cited by 25

Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer’s disease biomarkers

Ballerini, A., Biagioli, N., Carbone, C., Chiari, A., Tondelli, M., Vinceti, G., Bedin, R., Malagoli, M., Genovese, M., Scolastico, S., et al. (2024) · Brain · doi:10.1093/brain/awae207 · Cited by 24

Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures

Lin, R., Jones, N. C., & Kwan, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103676 · Cited by 24

Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma

Luwor, R. B., Morokoff, A. P., Amiridis, S., D’Abaco, G. M., Paradiso, L., Stylli, S. S., Nguyen, H. P. T., Tarleton, M., Young, K. A., O'Brien, T. J., et al. (2019) · Cancer Investigation · doi:10.1080/07357907.2019.1582060 · Cited by 23

Early preclinical plasma protein biomarkers of brain trauma are influenced by early seizures and levetiracetam

Saletti, P. G., Mowrey, W. B., Liu, W., Li, Q., McCullough, J., Aniceto, R., Lin, I., Eklund, M., Casillas-Espinosa, P. M., Ali, I. Y., et al. (2023) · Epilepsia Open · doi:10.1002/epi4.12738 · Cited by 19

Cracking novel shared targets between epilepsy and Alzheimer’s disease: need of the hour

Garg, N., Joshi, R., & Medhi, B. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0064 · Cited by 21

Astrocytic IGF‐1 and IGF‐1R Orchestrate Mitophagy in Traumatic Brain Injury via Exosomal miR‐let‐7e

Dabin, R., Chen, W., Shu, L., Ke, C., Wang, Z., & Zheng, P. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3504279 · Cited by 20

Neuroimaging in animal models of epilepsy

Bertoglio, D., Verhaeghe, J. A. J., Dedeurwaerdere, S., & Gröhn, O. H. J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.06.062 · Cited by 20

Pediatric traumatic brain injury and a subsequent transient immune challenge independently influenced chronic outcomes in male mice

Sharma, R., Casillas-Espinosa, P. M., Dill, L. K., Rewell, S. S. J., Hudson, M. R., O'Brien, T. J., Shultz, S. R., & Semple, B. D. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.013 · Cited by 19

Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice

Gan, C., Zou, Y., Xia, Y., Zhang, T., Chen, D., Lan, G., Mei, Y., Wang, L., Shui, X., Hu, L., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59922 · Cited by 19

Epileptiform GluN2B–driven excitation in hippocampus as a therapeutic target against temporal lobe epilepsy

Gorlewicz, A., Pijet, B., Orlova, K., Kaczmarek, L., & Knapska, E. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114087 · Cited by 19

Deficiency but Not Supplementation of Selenium Impairs the Hippocampal Long-Term Potentiation and Hippocampus-Dependent Learning

Babür, E., Tan, B., Yousef, M., Cinbaş, S., Süer, C., & Dursun, N. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-01666-x · Cited by 18

Targeted Reducing of Tauopathy Alleviates Epileptic Seizures and Spatial Memory Impairment in an Optogenetically Inducible Mouse Model of Epilepsy

Gao, Y., Zheng, J., Jiang, T., Pi, G., Sun, F., Xiong, R., Wang, W., Wu, D., Li, S., Lei, H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.633725 · Cited by 18

Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy

Putra, M. R. E., Rao, N. S., Gardner, C., Liu, G., Trommater, J., Bunney, M., Gage, M., Bassuk, A. G., Hefti, M. M., Lee, G. S., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae327 · Cited by 17

Knowledge atlas of post-traumatic epilepsy research: Based on citespace visualization analysis

Zhan, J., Ma, Y., Zhao, D., Li, Z., Tan, H., Wang, X., Liu, H., & Yang, T. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106790 · Cited by 17

Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions

Reddy, D. S., Golub, V. M., Ramakrishnan, S., Churn, S. B., Shapiro, L. A., Iannucci, J., Pitkänen, A., Galanopoulou, A. S., Maganti, R. K., & Boison, D. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100080 · Cited by 18

Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study

Vivash, L. E., Malpas, C. B., Hovens, C. M., Brodtmann, A. G., Collins, S. J., Macfarlane, S., Velakoulis, D., & O'Brien, T. J. (2021) · BMJ Neurology Open · doi:10.1136/bmjno-2021-000223 · Cited by 16

The genetic ablation of tau improves long-term, but not short-term, functional outcomes after experimental traumatic brain injury in mice

Tan, X. L., Zheng, P., Wright, D. K., Sun, M., Brady, R. D., Liu, S., McDonald, S. J., Mychasiuk, R., Cenap, S., Jones, N. C., et al. (2019) · Brain Injury · doi:10.1080/02699052.2019.1667539 · Cited by 16

Tau Phosphorylation Patterns in the Rat Cerebral Cortex After Traumatic Brain Injury and Sodium Selenate Effects: An Epibios4rx Project 2 Study

Saletti, P. G., Casillas-Espinosa, P. M., Lisgaras, C. P., Mowrey, W. B., Li, Q., Liu, W., Brady, R. D., Ali, I., Silva, J., Yamakawa, G. R., et al. (2023) · Journal of Neurotrauma · doi:10.1089/neu.2022.0219 · Cited by 16

The role of Rho/ROCK in epileptic seizure-related neuronal damage

Wang, Z., Ren, D., & Zheng, P. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00909-6 · Cited by 15

A phase 1b open‐label study of sodium selenate as a disease‐modifying treatment for possible behavioral variant frontotemporal dementia

Vivash, L. E., Malpas, C. B., Meletis, C., Gollant, M., Eratne, D., Li, Q., McDonald, S. J., O’Brien, W. T., Brodtmann, A. G., Darby, D., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12299 · Cited by 15

Preclinical Assessment of a New Hybrid Compound C11 Efficacy on Neurogenesis and Cognitive Functions after Pilocarpine Induced Status Epilepticus in Mice

Andres‐Mach, M., Szewczyk, A., Zagaja, M. P., Szala‐Rycaj, J., Lemieszek, M. K., Maj, M., Abram, M., & Kamiński, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063240 · Cited by 15

The study of microtubule dynamics and stability at the postsynaptic density in a rat pilocarpine model of temporal lobe epilepsy

Wu, X., Zhou, Y., Huang, Z., Cai, M., Shu, Y., Zeng, C., Feng, L., Xiao, B., & Zhan, Q. (2020) · Annals of Translational Medicine · doi:10.21037/atm-19-4636 · Cited by 14

Effects of altered tau expression on dentate granule cell excitability in mice

Cloyd, R., Koren, J., Abisambra, J. F., & Smith, B. N. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113766 · Cited by 15

Epileptic seizures induced by pentylenetetrazole kindling accelerate Alzheimer-like neuropathology in 5×FAD mice

Zou, Y., Wang, C., Li, H., Zhong, M., Lin, J., Hu, Y., Chen, Z., & Gan, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1500105 · Cited by 13

A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementia

Vivash, L. E., Malpas, C. B., Churilov, L. P., Walterfang, M., Brodtmann, A. G., Piguet, O., Ahmed, R. M., Bush, A. I., Hovens, C. M., Kalinčík, T., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040100 · Cited by 14

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial

Vivash, L. E., Bertram, K., Malpas, C. B., Marotta, C., Harding, I. H., Kolbe, S., Fielding, J., Clough, M., Lewis, S. J. G., Tisch, S. H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-055019 · Cited by 12

Integrated single-cell multiomics reveals novel immune candidate markers for post-traumatic coagulopathy

Zheng, P., Zhang, N., Ren, D., Yu, C., Zhao, B., Bai, Q., Zhang, Y., & Sun, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1095657 · Cited by 12

The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons

Habbab, W., Aoudé, I., Palangi, F., Abdulla, S., & Ahmed, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040844 · Cited by 12

Antiepileptic Drugs as Potential Dementia Prophylactics Following Traumatic Brain Injury

Locskai, L. F., Alyenbaawi, H., & Allison, W. T. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-013930 · Cited by 11

Early life adversity accelerates epileptogenesis and enhances depression-like behaviors in rats

Rupasinghe, R., Dezsi, G., Öztürk, E., Carron, S. F., Hudson, M. R., Casillas-Espinosa, P. M., & Jones, N. C. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114088 · Cited by 11

Associations between Serum Tau, Neurological Outcome, and Cognition following Traumatic Brain Injury

Zheng, P., Ni, P., Qiao, Y., Tong, W., & Zhao, C. (2020) · Neurology India · doi:10.4103/0028-3886.284380 · Cited by 10

Post-Traumatic Epilepsy in Zebrafish Is Drug-Resistant and Impairs Cognitive Function

Cho, S.-J., Park, E., BAKER, A. J., & Reid, A. Y. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0156 · Cited by 10

Phase II randomised placebo-controlled trial of sodium selenate as a disease-modifying treatment in chronic drug-resistant temporal lobe epilepsy: the SeLECT study protocol

Vivash, L. E., Johns, H. T., Churilov, L. P., MacPhail, S., Casillas-Espinosa, P. M., Malpas, C. B., Shultz, S. R., Tailby, C., Wijayath, M., Reutens, D. C., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-075888 · Cited by 9

Informatics tools to assess the success of procedural harmonization in preclinical multicenter biomarker discovery study on post-traumatic epileptogenesis

Ciszek, R., Ndode‐Ekane, X. E., Santana‐Gomez, C., Casillas-Espinosa, P. M., Ali, I. Y., Smith, G. S., Puhakka, N., Lapinlampi, N., Andrade, P., Kamnaksh, A., et al. (2018) · Epilepsy Research · doi:10.1016/j.eplepsyres.2018.12.010 · Cited by 9

Disease-Modifying Effects of Neural Regeneration Peptide 2945 in the GAERS Model of Absence Epilepsy

Dezsi, G., Sieg, F., Thomas, M., O'Brien, T. J., van der Hart, M., & Jones, N. C. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2305-x · Cited by 9

Fluoxetine accelerates epileptogenesis and magnifies disease severity in a rat model of acquired epilepsy

Dezsi, G., Öztürk, E., Wong, D., Hudson, M. R., Martello, G., Gomes, F. M. M., Salzberg, M. R., Morris, M. J., O'Brien, T. J., & Jones, N. C. (2024) · Epilepsia · doi:10.1111/epi.18080 · Cited by 8

Delayed treatment with ceftriaxone reverses the enhanced sensitivity of TBI mice to chemically-induced seizures

Romariz, S. A. A., Main, B. S., Harvey, A. C., Longo, B. M., & Burns, M. P. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288363 · Cited by 8

Research Progress on the Immune-Inflammatory Mechanisms of Posttraumatic Epilepsy

Dang, Y., & Wang, T. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01429-2 · Cited by 7

Animal Models of Acquired Epilepsy and Tauopathies

Zheng, P., Shultz, S. R., Hovens, C. M., & O'Brien, T. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00072-9 · Cited by 7

A comparison of the antiepileptogenic efficacy of two rationally chosen multitargeted drug combinations in a rat model of posttraumatic epilepsy

Hameed, M. Q., D’Ambrosio, R., Eastman, C. L., Hui, B., Lin, R., Vermudez, S. A. D., Liebhardt, A., Choe, Y., Klein, P., Rundfeldt, C., et al. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114962 · Cited by 5

The potential therapeutic role of berberine in treating epilepsy focusing on temporal lobe epilepsy: State of art and ongoing perspective

Alsfouk, B. A. A., Al-Kuraishy, H. M., Albuhadily, A. K., Al-Gareeb, A. I., Abdelaziz, A. M., Alexiou, A. T., Papadakis, M., Alruwaili, M., & Batiha, G. E. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111189 · Cited by 5

Amygdaloid complex anatomopathological findings in animal models of status epilepticus

Tilelli, C. Q., Flôres, L. R., Cota, V. R., de Castro, O. W., & Garcia‐Cairasco, N. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106831 · Cited by 5

Proteomic Assessment of C57BL/6 Hippocampi after Non-Selective Pharmacological Inhibition of Nitric Oxide Synthase Activity: Implications of Seizure-like Neuronal Hyperexcitability Followed by Tauopathy

Hendrickx, J. O., Adams, C., Sieben, A., Laukens, K., Dam, D. V., & Meyer, G. R. Y. D. (2022) · Biomedicines · doi:10.3390/biomedicines10081772 · Cited by 5

Astrocytic insulin‐like growth factor‐1 prevents excitotoxic downregulation of adenosine deaminase acting on RNA in calcium dynamics

Chen, W., He, B., & Zheng, P. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28184 · Cited by 5

Alzheimer’s disease and epilepsy: Research hotspots for comorbidity in the era of global aging

Zhou, X., Liu, Y., Wu, Z., Zhang, X., & Tao, H. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109849 · Cited by 4

Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.

Jones, N. C., Nguyen, T., Corcoran, N. M., Velakoulis, D., Chen, T., Grundy, R., O'Brien, T. J., & Hovens, C. M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.005 · Cited by 81

Sodium selenate reduces neurodegeneration and psychological comorbidities in a post-kainic acid status epilepticus rat model of temporal lobe epilepsy

Zheng, P. (2013) · Frontiers in Human Neuroscience · doi:10.3389/conf.fnhum.2013.212.00070

Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy

Casillas-Espinosa, P. M., Anderson, A., Harutyunyan, A., Li, C. N., Lee, J.-Y., Braine, E. L., Brady, R. D., Sun, M., Huang, C., Barlow, C. K., et al. (2023) · eLife · doi:10.7554/elife.78877 · Cited by 37

P3‐424: Sodium selenate specifically boosts PP2A phosphatase, dephosphorylates tau and reverses memory deficits and prevents neurofibrillary tangle formation in Alzheimer's disease models

Hovens, C. M., Ittner, L. M., Martin, D., Hutter‐Paier, B., Windisch, M., Nguyen, A., Costello, A. J., Götz, J., & Corcoran, N. M. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.05.1967 · Cited by 1

Pharmacokinetics and brain uptake of sodium selenate and selenium in naïve rats and a lateral fluid percussion injury rat model

Li, C., Casillas-Espinosa, P. M., Saletti, P. G., Chi, T., Yamakawa, G. R., Silva, J. C., Hudson, M., Liu, W., Jones, N. C., Shultz, S. R., et al. (2024) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1256 · Cited by 2